Guggenheim Capital LLC lifted its stake in shares of Agilent Technologies (NYSE:A) by 56.5% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,173,903 shares of the medical research company’s stock after purchasing an additional 423,668 shares during the period. Guggenheim Capital LLC owned approximately 0.36% of Agilent Technologies worth $78,617,000 at the end of the most recent quarter.
Other institutional investors also recently made changes to their positions in the company. BlackRock Inc. raised its position in Agilent Technologies by 8.1% during the fourth quarter. BlackRock Inc. now owns 25,665,358 shares of the medical research company’s stock valued at $1,718,808,000 after buying an additional 1,912,186 shares during the period. Renaissance Technologies LLC raised its position in Agilent Technologies by 325.0% during the fourth quarter. Renaissance Technologies LLC now owns 2,370,200 shares of the medical research company’s stock valued at $158,732,000 after buying an additional 1,812,500 shares during the period. Arrowstreet Capital Limited Partnership raised its position in Agilent Technologies by 145.4% during the fourth quarter. Arrowstreet Capital Limited Partnership now owns 1,726,929 shares of the medical research company’s stock valued at $115,652,000 after buying an additional 1,023,099 shares during the period. TimesSquare Capital Management LLC acquired a new position in Agilent Technologies during the third quarter valued at $58,550,000. Finally, Bank of Montreal Can raised its position in Agilent Technologies by 187.3% during the fourth quarter. Bank of Montreal Can now owns 742,001 shares of the medical research company’s stock valued at $49,693,000 after buying an additional 483,721 shares during the period.
In other news, Director Heidi Fields sold 5,000 shares of the stock in a transaction that occurred on Tuesday, March 27th. The stock was sold at an average price of $68.09, for a total value of $340,450.00. Following the completion of the transaction, the director now directly owns 57,563 shares of the company’s stock, valued at approximately $3,919,464.67. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Patrick Kaltenbach sold 4,000 shares of the stock in a transaction that occurred on Thursday, March 29th. The stock was sold at an average price of $67.28, for a total value of $269,120.00. Following the completion of the transaction, the insider now directly owns 72,547 shares of the company’s stock, valued at $4,880,962.16. The disclosure for this sale can be found here. In the last ninety days, insiders sold 110,103 shares of company stock valued at $7,868,537.
Several research firms recently weighed in on A. ValuEngine lowered Agilent Technologies from a “buy” rating to a “hold” rating in a research report on Wednesday, March 7th. Zacks Investment Research downgraded Agilent Technologies from a “buy” rating to a “hold” rating in a research note on Monday, March 26th. Morgan Stanley boosted their target price on Agilent Technologies from $90.00 to $95.00 and gave the company an “overweight” rating in a research note on Monday. Barclays restated a “buy” rating and issued a $74.00 target price on shares of Agilent Technologies in a research note on Monday, January 8th. Finally, Evercore ISI assumed coverage on Agilent Technologies in a research note on Wednesday, January 3rd. They issued an “outperform” rating and a $75.00 target price on the stock. Four analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. The stock has a consensus rating of “Buy” and an average target price of $72.77.
NYSE:A traded down $2.47 during mid-day trading on Monday, hitting $64.43. 2,949,179 shares of the company’s stock traded hands, compared to its average volume of 2,470,285. Agilent Technologies has a 12 month low of $52.26 and a 12 month high of $75.00. The company has a market cap of $21,573.65, a price-to-earnings ratio of 27.30, a PEG ratio of 2.23 and a beta of 1.31. The company has a quick ratio of 2.78, a current ratio of 3.23 and a debt-to-equity ratio of 0.40.
Agilent Technologies (NYSE:A) last posted its quarterly earnings results on Wednesday, February 14th. The medical research company reported $0.66 EPS for the quarter, beating the consensus estimate of $0.58 by $0.08. The firm had revenue of $1.21 billion during the quarter, compared to analysts’ expectations of $1.16 billion. Agilent Technologies had a return on equity of 17.70% and a net margin of 4.25%. During the same quarter in the prior year, the firm posted $0.53 EPS. analysts anticipate that Agilent Technologies will post 2.68 EPS for the current year.
The company also recently declared a quarterly dividend, which will be paid on Wednesday, April 25th. Shareholders of record on Tuesday, April 3rd will be issued a $0.149 dividend. The ex-dividend date is Monday, April 2nd. This represents a $0.60 annualized dividend and a yield of 0.93%. Agilent Technologies’s dividend payout ratio (DPR) is 25.42%.
TRADEMARK VIOLATION NOTICE: “Guggenheim Capital LLC Purchases 423,668 Shares of Agilent Technologies (NYSE:A)” was first reported by Enterprise Leader and is the property of of Enterprise Leader. If you are accessing this piece on another site, it was stolen and republished in violation of U.S. & international trademark and copyright law. The legal version of this piece can be viewed at https://theenterpriseleader.com/2018/04/02/agilent-technologies-inc-nysea-shares-bought-by-guggenheim-capital-llc.html.
Agilent Technologies Profile
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; microfluidics based automated electrophoresis products; cell analysis plate based assays; laboratory software and informatics systems; laboratory automation; dissolution testing; vacuum pumps; and measurement technologies.
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.